OF TAMOXIFEN BY RECOMBINANT HUMAN CYTOCHROME P 450 ENZYMES : FORMATION OF THE 4-HYDROXY , 4-HYDROXY AND N-DESMETHYL METABOLITES AND ISOMERIZATION OF trans-4-HYDROXYTAMOXIFEN

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.

  2001cited by this paper
• Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation.

  2000cited by this paper
• Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P450 1B1 variants in Escherichia coli.

  2000cited by this paper
• Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

  1999cited by this paper
• Immunohistochemical Localization of Cytochrome P450 CYP1B1 in Breast Cancer with Monoclonal Antibodies Specific for CYP1B1

  1999influential reference
• Catalytic properties of polymorphic human cytochrome P450 1B1 variants.

  1999cited by this paper
• Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium.

  1998cited by this paper
• Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline in the human breast.

  1998cited by this paper
• Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.

  1998cited by this paper
• Chaperone Coexpression Plasmids: Differential and Synergistic Roles of DnaK-DnaJ-GrpE and GroEL-GroES in Assisting Folding of an Allergen of Japanese Cedar Pollen, Cryj2, inEscherichia coli

  1998cited by this paper
• Regiospecific expression of cytochrome P4501A1 and 1B1 in human uterine tissue.

  1998cited by this paper
• Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: role of the Ah receptor.

  1998cited by this paper
• Drug metabolism by Escherichia coli expressing human cytochromes P450

  1997cited by this paper
• Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes.

  1997cited by this paper
• Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells.

  1997cited by this paper
• CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver.

  1997influential reference
• Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.

  1997cited by this paper
• Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.

  1996cited by this paper
• Expression of cytochromes P450 in human breast tissue and tumors.

  1996influential reference
• 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis.

  1995cited by this paper
• Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver.

  1995cited by this paper
• Expression of cytochrome P450 2D6 in Escherichia coli, purification, and spectral and catalytic characterization.

  1995cited by this paper
• Expression of cytochrome P450 CYP1B1 in breast cancer

  1995cited by this paper
• Identification of tamoxifen metabolites in human Hep G2 cell line, human liver homogenate, and patients on long-term therapy for breast cancer.

  1995cited by this paper
• Interindividual variation in the isomerization of 4-hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450.

  1994cited by this paper
• Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.

  1993cited by this paper
• Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.

  1993cited by this paper
• Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients.

  1992cited by this paper
• Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes.

  1991cited by this paper
• High efficiency transformation of Escherichia coli with plasmids.

  1990cited by this paper
• Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.

  1984cited by this paper
• Some chemical and biochemical aspects of liver microsomal metabolism of tamoxifen.

  1984cited by this paper
• Estrogenic and antiestrogenic activity of monophenolic analogues of tamoxifen, (Z)-2-[p-(1,2-diphenyl-1-butenyl)phenoxy]-N, N-dimethylethylamine.

  1982cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Characterization of Cytochrome P450 Enzymes in Human Breast Tissue from Reduction Mammaplasties*

  year unknowninfluential reference

• Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes.

  2015cites this paper
• Endoxifen and Other Metabolites of Tamoxifen Inhibit Human Hydroxysteroid Sulfotransferase 2 A 1 ( hSULT 2 A 1 ) s

  2014cites this paper
• Tumorigenesis and Neoplastic Progression Tamoxifen Modulates Cell Migration and Expression of Angiogenesis-Related Genes in Human Endometrial Endothelial Cells

  2012cites this paper
• Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

  2012cites this paper